Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Biosimilar nivolumab?Paten gabapentin 300?Ivermectin tablets shelf life manufacturer?Vyvanse price per pill?Methylprednisolone acetate?
See the DrugPatentWatch profile for doxylamine
Yes. Doxylamine succinate is classified as a first-generation H1 antihistamine. First-generation H1 blockers tend to be older antihistamines that commonly cause sedation and can cross into the brain, which matches doxylamine’s well-known drowsiness effect.
First-generation antihistamines generally: - Are more likely to cause sleepiness (sedation). - Have more “central nervous system” effects compared with many second-generation antihistamines, which are typically less sedating. Doxylamine is used in products where sedation is expected, such as some nighttime allergy and sleep-related formulations, consistent with first-generation behavior.
People sometimes search for “doxylamine” and “antihistamine” because it appears in multiple contexts (for example, sleep aids and allergy medicine). In those uses, doxylamine is still the same active ingredient and remains a first-generation antihistamine.
No sources were provided in the prompt.
Other Questions About Doxylamine :